Valneva could outsource Covid-19 vaccine manufacturing in response to demand
Valneva maps authorisation and manufacturing plans on the heels of positive Phase III Covid-19 vaccine data.
Therapy Areas
Covid-19: vaccine pricing varies wildly by country and company
As the vaccine inequity debate rages on, even nations with access to Covid-19 jabs are...
CHMP recommends Moderna’s Covid-19 vaccine booster shot in the EU
The Phase II data showed that the neutralising antibody titers have declined prior to boosting...
Russia approves Sputnik V Covid-19 vaccination with flu shot
Sputnik V has been developed by the Gamaleya National Research Institute of Epidemiology and Microbiology.
Merck’s molnupiravir: Covid-19 gamechanger status relies on patient risk factors
Molnupiravir access may depend on how risk factors are interpreted but availability could be wider...
EC grants approval to BMS’ Opdivo combo for gastroesophageal cancer
In a Phase III trial, Opdivo plus chemotherapy offered statistically significant improvement in overall survival.
Inovio signs MoU with Colombia to boost efforts to tackle Covid-19
The MoU will aid in creating production expertise for Inovio’s DNA drugs and technologies in the country.
Pfizer and BioNTech unveil postive data of Covid-19 booster shot trial
The efficacy of the booster dose of vaccine was consistent regardless of race, ethnicity, age, sex or comorbid conditions.
The ethics of vaccine boosters
With the variance in Covid-19 vaccine access, what are the ethics of promoting third booster shots to the world’s wealthiest?
Gut-skin axis may hold the answer to hidradenitis suppurativa
A recent study suggests hidradenitis suppurativa may be a good candidate indication for therapeutics acting via the gut-skin axis.
FDA grants EUA for Johnson & Johnson Covid-19 vaccine booster dose
The Vaccines and Related Biological Products Advisory Committee also recommended the authorisation of J&J’s booster shot.
